Invesco S&P 500 High Div Low Volatility ETF vs UnitedHealth Group Inc — how do they compare? Invesco S&P 500 High Div Low Volatility ETF trades at $48.82 (market cap $3.14B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 106× Invesco S&P 500 High Div Low Volatility ETF's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Invesco S&P 500 High Div Low Volatility ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invesco S&P 500 High Div Low Volatility ETF for 125 Days and UnitedHealth Group Inc for 97 Days on average.
| SPHD | UNH | |
|---|---|---|
Market Cap | $3.14B | $332.96B |
Volume | 1,461,349 | 7,273,749 |
52-Week High | $53.55 | $436.35 |
52-Week Low | $46.96 | $259.02 |
Typical Hold Time | 125 Days | 97 Days |
Sector | — | Health |
Enterprise Value | — | $374.82B |
Dividend Yield | — | 2.5% |
Signals from Pluang's Aura AI — not financial advice
SPHD trades at $48.81, up 1.29% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering monthly income, but financial ratios are not disclosed in the provided data. Recent news highlights its role in retirement income strategies, though some analysts favor competitors like SCHD for total returns.
Outlook: SPHD appeals for steady dividend income amid market volatility, but risks include underperformance versus peers and sensitivity to interest rate changes. Investors should weigh the trade-off between yield and growth potential.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →